SCHEMBL8285199

SCHEMBL8285199

CCOC(=O)c1cc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c2nc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.47
KDM4E B2RXH2 5/20 0.46
HTT P42858 3/20 0.46
HPGD P15428 4/20 0.44
ALDH1A1 P00352 4/20 0.44
RAB9A P51151 3/20 0.44
PDE4B Q07343 1/20 0.43
PNP P00491 1/20 0.43
MAPT P10636 6/20 0.43
NPC1 O15118 2/20 0.43
HSD17B10 Q99714 1/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
CDC25A P30304 1/20 0.42
CDC25B P30305 1/20 0.42
CDC25C P30307 1/20 0.42
TDP1 Q9NUW8 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285237 0.87 ALDH1A1 (0.41) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL8285200 0.85 MAPK1 (0.44) KDM4EHTTHPGDALDH1A1RAB9A
SCHEMBL8287153 0.85 MAPT (0.40) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL5872077 0.84 CSF1R (0.50) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL8287199 0.84 PDCD1 (0.40) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL8285197 0.84 CXCR2 (0.39) CSF1RKDM4EHPGDALDH1A1PDE4B
SCHEMBL8285210 0.83 PDE11A (0.44) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL8286414 0.82 CSF1R (0.47) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL8285235 0.82 PDE11A (0.41) CSF1RKDM4EHTTHPGDALDH1A1
SCHEMBL5871894 0.81 PDE11A (0.43) KDM4EHTTHPGDALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed